Skip to main content
NCBI home page
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1968 Feb;32(2):392–401. doi: 10.1111/j.1476-5381.1968.tb00981.x

The influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat.

D E Clarke, G D Leach
PMCID: PMC1570202  PMID: 4384657

Full text

PDF
392

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AXELROD J., HERTTING G., PATRICK R. W. Inhibition of H3-norepinephrine release by monoamine oxidase inhibitors. J Pharmacol Exp Ther. 1961 Dec;134:325–328. [PubMed] [Google Scholar]
  2. BHAGAT B. MODIFICATION OF THE EFFECTS OF GUANETHIDINE ON CARDIAC CATECHOL AMINES BY VARIOUS AGENTS. Br J Pharmacol Chemother. 1964 Apr;22:238–245. doi: 10.1111/j.1476-5381.1964.tb02029.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOURA A. L., COPP F. C., DUNCOMBE W. G., GREEN A. F., McCOUBREY A. The selective accumulation of bretylium in sympathetic ganglia and their postganglionic nerves. Br J Pharmacol Chemother. 1960 Jun;15:265–270. doi: 10.1111/j.1476-5381.1960.tb01242.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BOURA A. L., GREEN A. F. Adrenergic neurone blockade and other acute effects caused by N-benzyl-N'N"-dimethylguanidine and its ortho-chloro derivative. Br J Pharmacol Chemother. 1963 Feb;20:36–55. doi: 10.1111/j.1476-5381.1963.tb01295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BOURA A. L., GREEN A. F. The actions of bretylium: adrenergic neurone blocking and other effects. Br J Pharmacol Chemother. 1959 Dec;14:536–548. doi: 10.1111/j.1476-5381.1959.tb00961.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blaschko H., Richter D., Schlossmann H. The oxidation of adrenaline and other amines. Biochem J. 1937 Dec;31(12):2187–2196. doi: 10.1042/bj0312187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CALLINGHAM B. A., CASS R. The effects of bretylium and cocaine on noradrenaline depletion. J Pharm Pharmacol. 1962 Jun;14:385–389. doi: 10.1111/j.2042-7158.1962.tb11111.x. [DOI] [PubMed] [Google Scholar]
  8. COSTA E., KUNTZMAN R., GESSA G. L., BRODIE B. B. Structural requirements for bretylium and guanethidine-like activity. Life Sci. 1962 Mar;1:75–80. doi: 10.1016/0024-3205(62)90032-2. [DOI] [PubMed] [Google Scholar]
  9. Carlsson A., Waldeck B. The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine-treated mice. J Pharm Pharmacol. 1967 Mar;19(3):182–190. doi: 10.1111/j.2042-7158.1967.tb08063.x. [DOI] [PubMed] [Google Scholar]
  10. Clarke D. E., Hiscoe A., Hulley L. N., Jackson K., Leach G. D. A transistorised impulse generator for recording the heart rate from intact and isolated preparations. J Pharm Pharmacol. 1966 Jan;18(1):49–57. doi: 10.1111/j.2042-7158.1966.tb07771.x. [DOI] [PubMed] [Google Scholar]
  11. Fielden R., Green A. L. The effect of monoamine oxidase inhibition on guanethidine-induced noradrenaline release and sympathetic blockade. J Pharm Pharmacol. 1965 Jul;17(7):463–464. doi: 10.1111/j.2042-7158.1965.tb07705.x. [DOI] [PubMed] [Google Scholar]
  12. GESSA G. L., CUENCA E., COSTA E. On the mechanism of hypotensive effects of MAO inhibitors. Ann N Y Acad Sci. 1963 Jul 8;107:935–944. doi: 10.1111/j.1749-6632.1963.tb13336.x. [DOI] [PubMed] [Google Scholar]
  13. HERTTING G., AXELROD J., PATRICK R. W. Actions of bretylium and guanethidine on the uptake and release of [3H]-noradrenaline. Br J Pharmacol Chemother. 1962 Feb;18:161–166. doi: 10.1111/j.1476-5381.1962.tb01159.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Horita A. Selective brain monoamine oxidase inhibition resulting from an interaction between reversible and irreversible inhibitors. Int J Neuropharmacol. 1965 Nov;4(6):337–342. doi: 10.1016/0028-3908(65)90013-4. [DOI] [PubMed] [Google Scholar]
  15. KADZIELAWA K. Mechanism of action of guanethidine. Br J Pharmacol Chemother. 1962 Aug;19:74–84. doi: 10.1111/j.1476-5381.1962.tb01428.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. KUNTZMAN R., JACOBSON M. M. MONOAMINE OXIDASE INHIBITION BY A SERIES OF COMPOUNDS STRUCTURALLY RELATED TO BRETYLIUM AND GUANETHIDINE. J Pharmacol Exp Ther. 1963 Aug;141:166–172. [PubMed] [Google Scholar]
  17. MAXWELL R. A., PLUMMER A. J., SCHNEIDER F., POVALSKI H., DANIEL A. I. Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864). J Pharmacol Exp Ther. 1960 Jan;128:22–29. [PubMed] [Google Scholar]
  18. POTTER L. T., AXELROD J. Studies on the storage of norepinephrine and the effect of drugs. J Pharmacol Exp Ther. 1963 May;140:199–206. [PubMed] [Google Scholar]
  19. RYALL R. W. Effects of cocaine and antidepressant drugs on the nictitating membrane of the cat. Br J Pharmacol Chemother. 1961 Dec;17:339–357. doi: 10.1111/j.1476-5381.1961.tb01121.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SMITH E. R. The effect of norepinephrine infusions upon some responses of reserpine-treated spinal cats to tyramine. J Pharmacol Exp Ther. 1963 Mar;139:321–329. [PubMed] [Google Scholar]
  21. Spriggs T. L. Peripheral noradrenaline and adrenergic transmission in the rat. Br J Pharmacol Chemother. 1966 Jan;26(1):271–281. doi: 10.1111/j.1476-5381.1966.tb01830.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. TSAI T. H., FLEMING W. W. SYMPATHOMIMETIC ACTIONS OF MONOAMINE OXIDASE INHIBITORS IN THE ISOLATING NICITATING MEMBRANE OF THE CAT. Biochem Pharmacol. 1965 Mar;14:369–371. doi: 10.1016/0006-2952(65)90207-8. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES